M

McKesson

Supplies medicines and technology to healthcare teams

Biologics Payer Audit and Accreditation Specialist

Full-Time
$79.6k - $132.6k+ Annual bonus + Long-term incentive opportunities
Mid
Bachelor's
Texas, USA
RemoteApproximately 15% travel to Biologics sites for survey support, mock audits, and readiness activities.
Risk & ComplianceRegulatory Compliance & Ethics

About the job

Requirements
  • A degree or equivalent and typically 4+ years of relevant experience are required; a four-year undergraduate degree is preferred, and an equivalent combination of education and directly relevant experience will be considered.
  • At least 4 years of combined experience in specialty pharmacy, pharmacy operations, PBM, or pharmacy regulatory and payer compliance.
  • At least 2 years of PBM audit management and/or PBM auditor experience, including audit response, appeals, and recoupment defense, or at least 2 years of specialty pharmacy accreditation experience (URAC and/or ACHC), including standards interpretation, evidence submission, and survey support.
  • Working knowledge of pharmacy claims adjudication, claim rejections, and associated resolutions.
  • Demonstrated experience maintaining structured documentation, traceability, and corrective action follow-through.
  • Knowledge of pharmacy systems, pharmacy operations, and pharmacy workflow.
  • Ability to manage internal and external stakeholder expectations for service and issue resolution.
  • Ability to develop collaborative internal and external relationships and partnerships.
  • Strong documentation and organizational discipline, attention to detail, and follow-up.
  • Ability to communicate effectively with pharmacists, pharmacy staff, operations leaders, auditors, and surveyors.
  • Problem-solving, decision-making, interpersonal, written communication, analytical, and organizational skills.
  • Ability to manage multiple workstreams with competing deadlines and operate in a fast-paced, dynamic, regulated business environment.
  • Proficiency in Microsoft Office and technological aptitude.
  • Self-motivation and ability to work with limited direction or direct supervision.
Responsibilities
  • Support intake, logging, tracking, and timely response of PBM audit requests across Biologics sites, adhering to contractual and regulatory response deadlines.
  • Research audit findings, gather supporting documentation, and draft audit responses and appeals under the direction of the audit function owner.
  • Analyze audit findings and discrepancy trends by payer, site, drug, and discrepancy type to identify recurring root causes.
  • Maintain audit trackers, dashboards, and reporting for Operations, Quality, Finance, and Legal stakeholders.
  • Support interpretation and application of state pharmacy audit statutes, PBM provider manual terms, and contractual audit limitations.
  • Partner with Operations to recommend workflow and documentation changes that reduce audit exposure and recoupment risk.
  • Support URAC and ACHC accreditation maintenance, renewal application submission, and ongoing standards compliance across accredited sites.
  • Assist with gap analysis comparing current policies, SOPs, and operational practices with applicable accreditation standards.
  • Coordinate and upload accreditation evidence, track performance measure reporting, and support RFI response development and submission.
  • Support survey readiness, including mock audits, staff readiness materials, documentation review, and corrective-action follow-up.
  • Maintain accreditation documentation repositories, licensure and credentialing records, and version control.
  • Support continuous quality improvement initiatives, including quality improvement projects, CAPA tracking, and effectiveness monitoring.
  • Coordinate between Payer Audit, Accreditation, Quality, Operations, and Compliance stakeholders.
  • Prepare summaries, reports, and presentation materials for functional leadership and governance committees.
  • Maintain accurate, traceable, audit-ready documentation in accordance with internal standards and regulatory requirements.
  • Support development and delivery of staff-facing education and job aids related to audit readiness and accreditation standards.
Desired Qualifications
  • Certified Pharmacy Technician (CPhT) certification.
  • Specialty pharmacy experience.
  • Working knowledge of state pharmacy audit statutes and PBM provider manual audit provisions.
  • Experience with accreditation management platforms such as AccrediNet or document control systems such as MasterControl.
  • Experience with pharmacy management systems and reporting or analytics tools such as Power BI and Excel.
  • Community oncology, rare disease, or limited distribution drug experience.

About the company

McKesson distributes medicines and medical supplies to pharmacies, hospitals and other care providers, alongside services that connect drug manufacturers with patients. Its specialty businesses support community cancer care and clinical research, extending its work beyond moving products through warehouses. The company buys drugs and supplies from manufacturers for resale, while its software helps pharmacies manage inventory and healthcare teams secure insurance approval for prescriptions. It also sells practice management and patient support services to clinicians and drugmakers. McKesson traces its business roots to 1833 and is headquartered in Irving, Texas.

Company Size

10,001+

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1833

Get referred to McKesson

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Reinvestment has cash behind it: McKesson reported $6.2 billion operating cash flow for fiscal 2026 in May 2026.
  • Specialty expansion drives growth: McKesson reported 31% higher fiscal 2026 Oncology and Multispecialty sales in May 2026.
  • Technical candidates have openings: McKesson lists 154 information technology jobs on its career site in October 2026.

What critics are saying

  • One customer holds bargaining power: CVS generated 24% of McKesson's fiscal 2026 revenue, reported in May 2026.
  • Technology jobs face cuts: McKesson approved prescription technology headcount reductions during January through March 2026.
  • Medical supply careers face separation: McKesson outlined a planned Medical-Surgical IPO alongside Apollo's investment agreement in April 2026.

What makes McKesson unique

  • McKesson backs independent ownership: its Health Mart franchise supports pharmacies that remain independently owned and operated.
  • Generic purchasing has a retail partner: McKesson and Walmart jointly source medicines through ClarusONE.
  • McKesson reaches prescribing workflows: CoverMyMeds processes insurance approval requests free for clinicians across all plans and medications.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Performance Bonus
  • 401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

TradingView
Oct 6th, 2026
CD&R and McKesson to acquire Option Care Health.

CD&R and McKesson to acquire Option Care Health. WASHINGTON (dpa-AFX) - CD&R, McKesson (MCK) and Option Care Health (OPCH) have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. Upon completion, Option Care Health will become a privately held company. CD&R will hold a majority interest of approximately 51% in Option Care Health and McKesson will invest approximately $1.4 billion for a minority interest of approximately 49%. The deal establishes a framework for McKesson's future acquisition of CD&R's interest in Option Care Health, subject to specified conditions and regulatory approvals. Option Care Health is an independent provider of home and alternate site infusion services. In pre-market trading on NasdaqGS, Option Care shares are up 20.50 percent to $28.16. For More Such Health News, visit rttnews.com. Copyright(c) 2026 RTTNews.com. All Rights Reserved Copyright RTT News/dpa-AFX Read the full article

JH Consulting Online
Sep 22nd, 2026
Cara McDonough joins McKesson Medical-Surgical as Chief Product Strategy & Supplier Partnerships Officer.

Cara McDonough joins McKesson Medical-Surgical as Chief Product Strategy & Supplier Partnerships Officer. September 22, 2026- McKesson Medical-Surgical has announced that Cara McDonough has joined the organization as Chief Product Strategy & Supplier Partnerships Officer, effective September 14, 2026. In this role, Cara will lead McKesson Medical-Surgical's Product Strategy and Supplier Partnerships teams, guiding supplier relationship strategy and portfolio development across the company's Private Label, Pharmaceutical, Consumer Markets, and Laboratory businesses as a member of the Executive Committee. Cara brings 20 years of experience leading and growing product-focused organizations. Throughout her career, she has held senior leadership positions with nationally recognized companies, driving merchandising, private label, product strategy, and commercial growth across multiple channels, including B2B, e-commerce, and retail. Her experience building differentiated product portfolios, strengthening supplier relationships, and delivering profitable growth aligns closely with the organization's long-term strategy. As McKesson Medical-Surgical continues evolving its business, Cara's leadership will help further strengthen supplier partnerships and support the organization's commitment to delivering innovative solutions and value to customers.

McKesson Corporation
Sep 21st, 2026
McKesson Signs Agreement to Acquire Precision Medicine Group, LLC

McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (“Precision Medicine Group”), a global provider of clinical research and biopharma commercialization services.

Compass Oncology
Sep 15th, 2026
Compass Oncology earns first Green Building certification for a medical facility.

Compass Oncology earns first Green Building certification for a medical facility. Sep 15, 2026 What was once a vacant Toys "R" Us and BuyBuy Baby is now setting a new standard for sustainable healthcare At McKesson, Compass Oncology understand that the spaces where Compass Oncology work, distribute and care have a profound impact on its planet and people. In FY24, Compass Oncology developed McKesson's Green Building Standards (GBS) - an internal sustainability framework that provides guidance for eligible building design, construction and operations projects. Across its offices, distribution centers and eligible healthcare buildings, GBS is intended to support environmental performance, operational efficiency and employee well-being. Since inception, Compass Oncology has assessed 52 buildings and achieved 17 GBS certifications, including three Platinum, two Gold, 11 Silver and one Compliant. Compass Oncology, a practice in the US Oncology Network, recently became the first medical building to earn McKesson GBS certification at its East Cancer Center in Happy Valley, Oregon. The achievement is particularly notable because the facility was transformed from a former retail store into a modern healthcare environment developing its East Cancer Center, Compass Oncology partnered with the McKesson Real Estate team to repurpose the existing structure to GBS and create a space designed to support patients, caregivers and employees. Compass Oncology's East Cancer Center earned GBS Silver credit through a range of sustainability and wellness-focused features: * Energy and performance: High-efficiency HVAC systems and STAR appliances * Air Quality & Health: Enhanced air filtration supporting an indoor environment * Water Stewardship: Water-efficient plumbing fixtures that conserve resources * Materials & Carbon Impact: Adaptive reuse strategies that embodied carbon * Wellness & Experience: Bike racks and a thoughtfully designed garden that support employee well-being "At McKesson, we believe advancing health outcomes includes a commitment to creating healthier environments for the people and communities we serve, said Nimesh Jhaveri, R.Ph., Executive Vice President and Chief Impact Officer at McKesson. "Compass Oncology's achievement is an important milestone, not only as the first medical building to earn Green Building Standards certification, but also as a powerful example of how sustainability can be integrated into healthcare settings." Congratulations to Compass Oncology and the McKesson Real Estate team on this pioneering accomplishment!